A Study Looking at the Safety and Levels of PF-06823859 in Healthy Japanese Participants, and to see if Participants Had an Immune Response Against PF-06823859. A Phase 1, Randomized, Double-Blind, Sponsor- Open, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity and Pharmacokinetics Following Single Intravenous Dose of PF-06823859 in Japanese Healthy Participants.